ORUKA THERAPEUTICS, INC. Cash Flow Charts

1 years of history · ending 2024-12-31 · SEC EDGAR

Source:10-K · 10-Q

Capital Allocation

How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).

Capital Allocation Waterfall

Buybacks vs Stock-Based Comp

Cash Flow

Cash Flow by Activity

Operating Cash Flow
$-58M
Free Cash Flow
$-58M
Investing Cash Flow
$-330M
Financing Cash Flow
$450M
Capex
$189K
Stock-Based Comp
$15M
D&A
$27K
SBC Allocated Expense
$15M